Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Reply to E. Smyth et al.

Hulshof MC, Oppedijk V, van der Gaast A.

J Clin Oncol. 2014 Jul 28. pii: JCO.2014.56.3866. [Epub ahead of print] No abstract available.

PMID:
25071131
[PubMed - as supplied by publisher]
2.

A phase I pharmacokinetic study of the vascular disrupting agent ombrabulin (AVE8062) and docetaxel in advanced solid tumours.

Eskens FA, Tresca P, Tosi D, Van Doorn L, Fontaine H, Van der Gaast A, Veyrat-Follet C, Oprea C, Hospitel M, Dieras V.

Br J Cancer. 2014 Apr 29;110(9):2170-7. doi: 10.1038/bjc.2014.137. Epub 2014 Apr 8.

PMID:
24714750
[PubMed - indexed for MEDLINE]
3.

Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.

Oppedijk V, van der Gaast A, van Lanschot JJ, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema JC, Rütten H, Spruit PH, Reinders JG, Richel DJ, van Berge Henegouwen MI, Hulshof MC.

J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13.

PMID:
24419108
[PubMed - indexed for MEDLINE]
4.

Nurse-led follow-up at home vs. conventional medical outpatient clinic follow-up in patients with incurable upper gastrointestinal cancer: a randomized study.

Uitdehaag MJ, van Putten PG, van Eijck CH, Verschuur EM, van der Gaast A, Pek CJ, van der Rijt CC, de Man RA, Steyerberg EW, Laheij RJ, Siersema PD, Spaander MC, Kuipers EJ.

J Pain Symptom Manage. 2014 Mar;47(3):518-30. doi: 10.1016/j.jpainsymman.2013.04.006. Epub 2013 Jul 20.

PMID:
23880585
[PubMed - in process]
5.

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.

Lutz MP, Zalcberg JR, Ducreux M, Ajani JA, Allum W, Aust D, Bang YJ, Cascinu S, Hölscher A, Jankowski J, Jansen EP, Kisslich R, Lordick F, Mariette C, Moehler M, Oyama T, Roth A, Rueschoff J, Ruhstaller T, Seruca R, Stahl M, Sterzing F, van Cutsem E, van der Gaast A, van Lanschot J, Ychou M, Otto F; First St Gallen EORTC Gastrointestinal Cancer Conference 2012 Expert Panel.

Eur J Cancer. 2012 Nov;48(16):2941-53. doi: 10.1016/j.ejca.2012.07.029. Epub 2012 Aug 23.

PMID:
22921186
[PubMed - indexed for MEDLINE]
6.

Preoperative chemoradiotherapy for esophageal or junctional cancer.

van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A; CROSS Group.

N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.

PMID:
22646630
[PubMed - indexed for MEDLINE]
Free Article
7.

Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study.

van Hagen P, Spaander MC, van der Gaast A, van Rij CM, Tilanus HW, van Lanschot JJ, Wijnhoven BP; Rotterdam Oesophageal Tumour Study Group.

Int J Clin Oncol. 2013 Apr;18(2):214-9. doi: 10.1007/s10147-011-0362-8. Epub 2011 Dec 23.

PMID:
22193638
[PubMed - indexed for MEDLINE]
8.

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.

Boonstra JJ, Kok TC, Wijnhoven BP, van Heijl M, van Berge Henegouwen MI, Ten Kate FJ, Siersema PD, Dinjens WN, van Lanschot JJ, Tilanus HW, van der Gaast A.

BMC Cancer. 2011 May 19;11:181. doi: 10.1186/1471-2407-11-181.

PMID:
21595951
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer.

van Heijl M, Omloo JM, van Berge Henegouwen MI, Hoekstra OS, Boellaard R, Bossuyt PM, Busch OR, Tilanus HW, Hulshof MC, van der Gaast A, Nieuwenhuijzen GA, Bonenkamp HJ, Plukker JT, Cuesta MA, Ten Kate FJ, Pruim J, van Dekken H, Bergman JJ, Sloof GW, van Lanschot JJ.

Ann Surg. 2011 Jan;253(1):56-63. doi: 10.1097/SLA.0b013e3181f66596.

PMID:
21233607
[PubMed - indexed for MEDLINE]
10.

Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.

Morak MJ, Richel DJ, van Eijck CH, Nuyttens JJ, van der Gaast A, Vervenne WL, Padmos EE, Schaake EE, Busch OR, van Tienhoven G.

Radiother Oncol. 2011 Feb;98(2):261-4. doi: 10.1016/j.radonc.2010.10.016. Epub 2010 Nov 12.

PMID:
21075468
[PubMed - indexed for MEDLINE]
11.

Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours.

Konings IR, de Jonge MJ, Burger H, van der Gaast A, van Beijsterveldt LE, Winkler H, Verweij J, Yuan Z, Hellemans P, Eskens FA.

Br J Cancer. 2010 Sep 28;103(7):987-92. doi: 10.1038/sj.bjc.6605867. Epub 2010 Sep 7.

PMID:
20823884
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.

Konings IR, van der Gaast A, van der Wijk LJ, de Jongh FE, Eskens FA, Sleijfer S.

Eur J Cancer. 2010 Dec;46(18):3200-4. doi: 10.1016/j.ejca.2010.07.036. Epub 2010 Aug 18.

PMID:
20727735
[PubMed - indexed for MEDLINE]
13.

WITHDRAWN: Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction.

Homs MY, van der Gaast A, Siersema PD, Steyerberg EW, Kuipers EJ.

Cochrane Database Syst Rev. 2010 May 12;(5):CD004063. doi: 10.1002/14651858.CD004063.pub3. Review.

PMID:
20464727
[PubMed - indexed for MEDLINE]
14.

Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses.

Wijnhoven BP, van Lanschot JJ, Tilanus HW, Steyerberg EW, van der Gaast A.

World J Surg. 2009 Dec;33(12):2606-14. doi: 10.1007/s00268-009-0223-z. Review.

PMID:
19760309
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement.

Boonstra JJ, Koppert LB, Wijnhoven BP, Tilanus HW, Van Dekken H, Tran TC, Van der Gaast A.

J Surg Oncol. 2009 Oct 1;100(5):407-13. doi: 10.1002/jso.21358.

PMID:
19653239
[PubMed - indexed for MEDLINE]
16.

Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience.

van Meerten E, van der Gaast A, Tilanus HW, Poley JW, Muller K, van Dekken H.

J Surg Oncol. 2009 Jul 1;100(1):32-7. doi: 10.1002/jso.21295.

PMID:
19402081
[PubMed - indexed for MEDLINE]
17.

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.

Morak MJ, van der Gaast A, Incrocci L, van Dekken H, Hermans JJ, Jeekel J, Hop WC, Kazemier G, van Eijck CH.

Ann Surg. 2008 Dec;248(6):1031-41. doi: 10.1097/SLA.0b013e318190c53e.

PMID:
19092348
[PubMed - indexed for MEDLINE]
18.

Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.

Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, van der Gaast A, Stassen LP, Kuipers EJ, Siersema PD.

Br J Cancer. 2009 Jan 13;100(1):70-6. doi: 10.1038/sj.bjc.6604811. Epub 2008 Dec 9.

PMID:
19066612
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).

van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, van Dekken H, Wijnhoven BP, Tilanus HW, Richel DJ, Busch OR, Bartelsman JF, Koning CC, Offerhaus GJ, van der Gaast A.

BMC Surg. 2008 Nov 26;8:21. doi: 10.1186/1471-2482-8-21.

PMID:
19036143
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial).

van Heijl M, Omloo JM, van Berge Henegouwen MI, Busch OR, Tilanus HW, Bossuyt PM, Hoekstra OS, Stoker J, Hulshof MC, van der Gaast A, Nieuwenhuijzen GA, Bonenkamp HJ, Plukker JT, Bilgen EJ, Ten Kate FJ, Boellaard R, Pruim J, Sloof GW, van Lanschot JJ.

BMC Med Phys. 2008 Jul 31;8:3. doi: 10.1186/1756-6649-8-3.

PMID:
18671847
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk